Guest post

Is Medicine a Big Data Problem?

By Ted Driscoll / March 21, 2014 / 0 Comments

Human beings are big data. We aren’t just 175 pounds of meat and bone. We aren’t just piles of hydrogen and carbon and oxygen. What makes us all different is how it’s all organized and that is information.
We can no longer treat people based on simple numbers like weight, pulse, blood pressure, and temperature. What makes us different is much more complicated than that.

Read More

Exciting New Acquisition: ecoATM Acquired By Coinstar, now called Outerwall

By Randy Hawks / July 2, 2013 / 0 Comments

I am thrilled to announce today that Coinstar, now called Outerwall (NASDAQ:OUTR), the publicly held purveyor of 64,000 coin-counting and Redbox movie and video game rental kiosks, has acquired Claremont Creek portfolio company ecoATM for $350 million in cash.  What a promising acquisition it is! ecoATM makes automated, self-serve kiosks that quickly evaluate and buy back […]

Read More

Cleantech Startup Investing Out of Favor? Not So for Corporate Investors

By Paul Straub / April 9, 2013 / 0 Comments

April 8, 2013  source: This article was originally published on PEHub Many VCs have pulled back from funding energy technologies and cleantech startups, and have been replaced by corporate venture capitalists. Entrepreneurs and traditional VCs alike are finding opportunities where corporate partners provide a critical ingredient that substantially increases their likelihood of success. During the […]

Read More

The Golden Age of Healthcare Investing is Now

By Ted Driscoll / March 11, 2013 / 0 Comments

The human genome evolved for us as Paleolithic cavemen, arming us to cope with leopards, communicable diseases, infections, parasites and starvation. But modern society has succeeded in taming most of those risks, and now, ironically, our biggest health challenges are largely a byproduct of our success. As we extend our lifespan, cancer and cardiac disease increase in incidence. We confront an epidemic of diabetes and obesity related diseases largely caused by overconsumption and inactivity. Our genome never evolved to benefit obese 70 year olds. Cavemen didn’t typically live past 40 and didn’t drink high-fructose corn syrup in Big Gulps.

Read More

Ted Driscoll featured in Pharmalot, Op-Ed: Entering The Golden Age Of Big Data

By Claremont Creek Alerts / February 23, 2013 / 0 Comments

February 20, 2013   source: the original post by Ed Silverman appeared in Pharmalot As drug development and diagnostics increasingly converge, the advent of personalized medicine is increasing all the time. Of course, we are not quite there yet, but the advent of electronic medical records and the genome are inching us closer all the time. But […]

Read More
Venture Beat

VentureBeat article on Energy Management sector, a key market for Claremont Creek investments

By Claremont Creek Alerts / January 17, 2013 / 0 Comments

January 17, 2013 source: VentureBeat Ashley Halligan, an analyst at Austin, Texas-based Software Advice — recently published an article on VentureBeat in December outlining the growing trend in VC-funded digital cleantech–shifting from typical hardware-based investing. The article draws attention to interesting statistics including: there’s almost five million commercial facilities in the U.S. They account for […]

Read More

Meet our team

Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.

Nat_Boldhaber7718 -1200px

NAT GOLDHABER

Nat Goldhaber is a co-founder of Claremont Creek Ventures. 

Brad_Webb8124 1200px crop

BRAD WEBB

Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.

Randy_Hawks7690 -1200px

RANDY HAWKS

Randy Hawks is a co-founder of Claremont Creek Ventures.

Post Categories

Archives